SIPLIMI
DEAD

Serial Number

97716678

Owner

TEVA PHARMACEUTICALS USA, Inc.

Attorney

Lori Wolfe

Filing Date

Dec 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

SIPLIMI Trademark

Serial Number: 97716678

SIPLIMI is a trademark filed by TEVA PHARMACEUTICALS USA, Inc. on December 14, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

TEVA PHARMACEUTICALS USA, Inc.

Building A
Parsippany, NJ 07054

Entity Type: 03

Trademark Details

Filing Date

December 14, 2022

Registration Date

Not Registered

Published for Opposition

October 24, 2023

Goods & Services

Pharmaceutical preparations for the prevention and treatment of inflammatory and autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 18, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 18, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 18, 2026 REAP
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 19, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 19, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jun 2, 2025 EX3G
SOU EXTENSION 3 FILED
Jun 2, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 3, 2024 EXRA
SOU EXTENSION 2 GRANTED
Dec 3, 2024 EX2G
SOU EXTENSION 2 FILED
Dec 3, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 3, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jun 4, 2024 EX1G
SOU EXTENSION 1 FILED
Jun 4, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 4, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 18, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 18, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 18, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 18, 2023 CNEA
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2023 NWOS
NEW APPLICATION ENTERED
Dec 17, 2022 NWAP